Jim Simons Helius Medical Technologies, Inc. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.14 - $0.25 $30,380 - $54,250	217,000 Added 2047.17%	227,600 $44,000
Q1 2023 May 12, 2023	SELL	$0.23 - $0.41 $34,270 - $61,089	-149,000 Reduced 93.36%	10,600 $3,000
Q4 2022 Feb 13, 2023	SELL	$0.22 - $0.35 $31,892 - $50,737	-144,964 Reduced 47.6%	159,600 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.36 - $1.58 $92,949 - $407,946	258,194 Added 556.81%	304,564 $84,000
Q2 2022 Aug 12, 2022	BUY	$1.14 - $3.48 $7,131 - $21,770	6,256 Added 15.6%	46,370 $55,000

Q1 2022 May 13, 2022	BUY	$3.07 - $5.55 $4,126 - $7,459	1,344 Added 3.47%	40,114 $133,000
Q4 2021 Feb 11, 2022	BUY	$5.12 - $14.5 $7,680 - $21,750	1,500 Added 4.02%	38,770 $201,000
Q3 2021 Nov 12, 2021	SELL	$12.9 - $16.83 $47,730 - $62,270	-3,700 Reduced 9.03%	37,270 $537,000
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.45 $47,808 - $66,420	-3,600 Reduced 8.08%	40,970 $696,000
Q1 2021 May 13, 2021	BUY	$11.23 - $18.35 $500,521 - $817,859	44,570 New	44,570 $801,000

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $20.3M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.